Is Reliance Global Group a Good Insurance Broker Stock to Buy?

: RELI | Reliance Global Group Inc. News, Ratings, and Charts

RELI – The shares of insurance broker Reliance Global (RELI) have soared in price thanks to the company’s expanding product offerings and market reach. However, since RELI has yet to turn a profit, is it wise to bet on the stock now? Read on to learn our view.

Advanced insurance agency Reliance Global Group, Inc. (RELI) in Lakewood, N.J., is making progress by rapidly adding new states to the nationwide rollout of its 5MinuteInsure.com platform. 

Simultaneously, RELI is exploring opportunistic acquisitions of cash-flow-positive agencies at attractive multiples to expand its national footprint further and enhance its operating efficiency. The stock has a consensus rating of ‘Buy.’

In terms of the trailing-12-month asset turnover ratio, RELI’s 0.41% is 93.8% higher than the 0.21% industry average. In addition, the stock has gained 249.7% in price over the past month and 153.9% over the past three months to close yesterday’s trading session at $6.75. And its revenues are expected to increase with the reopening of the economy. So, RELI’s near-term prospects look bright.

So, here is what I think could influence RELI’s performance in the coming months:

Improving Financials

RELI’s revenues increased 54% year-over-year to $2.58 million in the third quarter, ended Sept. 30, 2021. The company’s EBITDA loss declined 88% year-over-year to $87,000, while its net loss came in at $595,233, representing a 51.7% year-over-year decrease. Also, its loss per share was  $0.05, down 83.3% year-over-year.

Growth Initiatives

On Dec.22, 2021, RELI announced a definitive agreement to acquire Medigap Health Insurance Company. Ezra Beyman, RELI’s CEO, said, “This planned acquisition would expand our capabilities within the Medicare supplement market, which we believe would be a perfect complement and highly synergistic with our existing portfolio companies. In addition to bolstering our revenue by more than 70%, we believe this transaction has the potential to be highly accretive.”

Selling Shares to Fund Growth Activities

On Dec.23, 2021, RELI priced a private placement of preferred stock, common stock, and warrants for gross proceeds of $20 million. The company intends to use the net proceeds from the private placement to fund its planned acquisition of Medigap, to support expanded marketing activities around 5MinuteInsure.com, and for general working capital and administrative purposes.

Bottom Line

RELI has been showing continued revenue growth and scalability of its business model. Also, we think it is well-positioned to benefit from the expected rise in interest rates. So, it could be wise to add the stock to one’s watch list.


RELI shares were trading at $5.88 per share on Friday afternoon, down $0.87 (-12.89%). Year-to-date, RELI has declined -8.70%, versus a -1.67% rise in the benchmark S&P 500 index during the same period.


About the Author: Nimesh Jaiswal


Nimesh Jaiswal's fervent interest in analyzing and interpreting financial data led him to a career as a financial analyst and journalist. The importance of financial statements in driving a stock’s price is the key approach that he follows while advising investors in his articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
RELIGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

How to Beat the Market the Rest of the Year?

The easy gains that came at the start of this new bull market are fading away fast. In fact the stock market (SPY) has become quite volatile with 2022 starting off with a nasty correction. Gladly there are easy solutions as will be shared in this commentary to get you on the right path to outperform the market the rest of the year. Read the rest below...

:  |  News, Ratings, and Charts

3 Stocks that Are Thriving in an Inflationary Environment

Inflation is one of the biggest threats facing the economy. One profitable strategy during this period of high inflation is to focus on stocks that have pricing power, as these companies’ margins will continue to expand. In contrast, stocks without pricing power are likely to underperform as margin compression erodes EPS. Therefore, investors should consider buying these 3 stocks that are thriving in this inflationary environment: Olin (OLN), Nucor (NUE), and Chemours (CC).

:  |  News, Ratings, and Charts

Stock Market “Nausea Index” Going Off

The stock market (SPY) has seen fresh lows this week scaring many investors into selling their positions. On the other hand, 40 year investment veteran shares a proprietary market indicator that points to a significant bounce coming soon. Is he right? You be the judge by reading below.

:  |  News, Ratings, and Charts

4 Best Value Stocks to Buy in January

In times of high inflation, value stocks tend to outperform growth stocks and have done so over the past year. Amid the rising inflationary pressure and looming interest rate hikes, fundamentally sound value stocks ArcelorMittal (MT), Covestro (COVTY), KT Corporation (KT), and Nature’s Sunshine (NATR) could be solid bets.

:  |  News, Ratings, and Charts

Stock Market “Nausea Index” Going Off

The stock market (SPY) has seen fresh lows this week scaring many investors into selling their positions. On the other hand, 40 year investment veteran shares a proprietary market indicator that points to a significant bounce coming soon. Is he right? You be the judge by reading below.

Read More Stories

More Reliance Global Group Inc. (RELI) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All RELI News